These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9477973)

  • 21. Isolation from spleen of a 57-kDa protein substrate of the tyrosine kinase Lyn. Identification as a protein related to protein disulfide-isomerase and localisation of the phosphorylation sites.
    Donella-Deana A; James P; Staudenmann W; Cesaro L; Marin O; Brunati AM; Ruzzene M; Pinna LA
    Eur J Biochem; 1996 Jan; 235(1-2):18-25. PubMed ID: 8631326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY; Harte RA; Cartwright CA
    Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells.
    Suzuki T; Shoji S; Yamamoto K; Nada S; Okada M; Yamamoto T; Honda Z
    J Immunol; 1998 Oct; 161(7):3694-701. PubMed ID: 9759894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
    Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
    Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
    Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
    Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linear and cyclic synthetic peptides related to the main autophosphorylation site of the Src tyrosine kinases as substrates and inhibitors of Lyn.
    Ruzza P; Calderan A; Filippi B; Biondi B; Deana AD; Cesaro L; Pinna LA; Borin G
    Int J Pept Protein Res; 1995 Jun; 45(6):529-39. PubMed ID: 7558583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antennapedia/HS1 chimeric phosphotyrosyl peptide: conformational properties, binding capability to c-Fgr SH2 domain and cell permeability.
    Ruzza P; Donella-Deana A; Calderan A; Brunati A; Massimino ML; Elardo S; Mattiazzo A; Pinna LA; Borin G
    Biopolymers; 2001; 60(4):290-306. PubMed ID: 11774232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells.
    Price DJ; Rivnay B; Avraham H
    Biochem Biophys Res Commun; 1999 Jun; 259(3):611-6. PubMed ID: 10364466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activation loop in Lck regulates oncogenic potential by inhibiting basal kinase activity and restricting substrate specificity.
    Laham LE; Mukhopadhyay N; Roberts TM
    Oncogene; 2000 Aug; 19(35):3961-70. PubMed ID: 10962552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular features underlying the sequential phosphorylation of HS1 protein and its association with c-Fgr protein-tyrosine kinase.
    Brunati AM; Donella-Deana A; James P; Quadroni M; Contri A; Marin O; Pinna LA
    J Biol Chem; 1999 Mar; 274(11):7557-64. PubMed ID: 10066823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective effect of poly(lysine) on the enhancement of the lyn tyrosine protein kinase activity. Increased specificity toward src peptides.
    Donella-Deana A; Marin O; Brunati AM; Pinna LA
    Eur J Biochem; 1992 Mar; 204(3):1159-63. PubMed ID: 1372554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.
    Sotirellis N; Johnson TM; Hibbs ML; Stanley IJ; Stanley E; Dunn AR; Cheng HC
    J Biol Chem; 1995 Dec; 270(50):29773-80. PubMed ID: 8530369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.
    Superti-Furga G; Fumagalli S; Koegl M; Courtneidge SA; Draetta G
    EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of autophosphorylation on the catalytic and regulatory properties of protein tyrosine kinase Src.
    Sun G; Ramdas L; Wang W; Vinci J; McMurray J; Budde RJ
    Arch Biochem Biophys; 2002 Jan; 397(1):11-7. PubMed ID: 11747305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
    Chong YP; Ia KK; Mulhern TD; Cheng HC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrotyrosine mimics phosphotyrosine binding to the SH2 domain of the src family tyrosine kinase lyn.
    Mallozzi C; Di Stasi AM; Minetti M
    FEBS Lett; 2001 Aug; 503(2-3):189-95. PubMed ID: 11513880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and Lyn.
    Agostinis P; Donella-Deana A; Van Hoof C; Cesaro L; Brunati AM; Ruzzene M; Merlevede W; Pinna LA; Goris J
    Eur J Biochem; 1996 Mar; 236(2):548-57. PubMed ID: 8612628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Src family kinases: regulation of their activities, levels and identification of new pathways.
    Ingley E
    Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites.
    Pellicena P; Stowell KR; Miller WT
    J Biol Chem; 1998 Jun; 273(25):15325-8. PubMed ID: 9624111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.